Patent ID: 6562586
Filing Date: 2003-05-13
Classification: C12N,C12Q

Abstract:
A method to identify a compound or protocol for the treatment of viral infection or virally-induced immunodeficiency, which method comprises maintaining a histoculture system in the presence and absence of said compound or protocol,monitoving the progress of viral infection or virally-induced immunodeficiency in the presence and absence of said compound or protocol; and comparing the progress of infection or virally-induced immunodeficiency in the presence and absence of said compound or protocol, whereby an inhibition of viral growth or improvement in immune status in the presence as opposed to the absence of said compound or protocol indicates effectiveness of the compound or protocol in inhibiting viral growth or ameliorating virally-induced immunodeficiency; wherein said histoculture system comprises a flexible macromolecular, porous matrix having a trabecular structure, and supported thereon, an integral macroscopic section of animal lymph node tissue, said tissue having been infected with an amount of virus effective to maintain growth of the virus, said matrix immersed in a suitable culture medium wherein the surface of the medium is approximately congruent with the interface between the tissue and the matrix, whereby the tissue architecture is preserved.